HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity.

Abstract
The diurnal profiles of pancreatic glucagon, insulin, pancreatic polypeptide (PP), and enteroglucagon were studied in five obese non-diabetic subjects (195 +/- 11 per cent of ideal body weight) and in six age matched controls. All the subjects were served with ordinary mixed meals five times during the day. The obese subjects were normoglycemic but hyperinsulinemic. Both groups showed rapid increases in PP to all meals, but the PP-response was significantly impaired in the obese group during the first part of the day. Normal subjects showed significant enteroglucagon responses to all meals, and had elevated levels throughout the day. In obese subjects, levels and responses were much lower at all times. Pancreatic glucagon profiles were similar. It is concluded that the possible role of abnormalities of PP and enteroglucagon secretion in the pathogenesis of human obesity deserves further study.
AuthorsJ J Holst, T W Schwartz, N A Lovgreen, O Pedersen, H Beck-Nielsen
JournalInternational journal of obesity (Int J Obes) Vol. 7 Issue 6 Pg. 529-38 ( 1983) England
PMID6360922 (Publication Type: Journal Article)
Chemical References
  • Gastrointestinal Hormones
  • Insulin
  • Pancreatic Polypeptide
  • Glucagon-Like Peptides
  • Glucagon
Topics
  • Adult
  • Animals
  • Circadian Rhythm
  • Female
  • Gastrointestinal Hormones (blood)
  • Glucagon (blood, metabolism)
  • Glucagon-Like Peptides (blood, metabolism)
  • Humans
  • Hyperinsulinism (blood, complications)
  • Insulin (blood, metabolism)
  • Insulin Secretion
  • Male
  • Mice
  • Obesity (blood, complications)
  • Pancreatic Polypeptide (blood, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: